u/alcohol_aversion

swirl, never shake

Cosigning on lot matching. It sounds trivial and it predicts almost everything else about how an operation is run.

Ask what the stability statement was written against — temperature, light, and whether it was the lyophilised powder or the reconstituted solution. Those are three different claims.

The system suitability argument, since it comes up whenever somebody posts a number without one.

Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.

None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.

Reconstituted at 1mL when I meant to use a different volume. Caught it because the units looked wrong on the barrel. Now I write 5mg/mL on the glass before I put the cap back.

ask for the storage condition the stability statement was written against

aim the stream at the glass wall, not at the cake

Small fix — that was the cardiovascular outcomes trial, so weight was a secondary endpoint and the population was different.

ask for the batch record before you ask for a discount

That reads like a titration plan and this board cannot give you one. Somebody who actually knows your history has to.

Ask what the stability statement was written against — temperature, light, and whether it was the lyophilised powder or the reconstituted solution. Those are three different claims.

Right. And a blank between injections settles the carryover argument before it starts.

Right — trial participants get structured support.

Adding the check nobody runs — the registered protocol is public and takes two minutes to compare.

Spent 9 weeks confused about this until somebody drew the table for me. 15mg, 3mL, 5mg/mL, 2mg is 40 units. That is the whole thing.

Lead time and minimum quantity are the two facts people forget to ask for and then argue about later. Both are answerable in one email before you commit.

STEP-1 averaged just under 15% at 68 weeks, so a 10% year is not a failure

Open-label extensions lose their randomisation. Anybody still enrolled at week 104 is a selected group and the numbers describe that group.

Asked HJ for the batch-specific certificate and had the full document — batch, date, method line naming the column — inside six hours. That is now my baseline for everybody.

Started reporting my own integrations with the baseline choice stated. Arguments in my threads dropped by about half.

How old is the column and roughly how many injections has it seen?

anya_erdogan is right — the integration choice is a decision and it should be stated alongside the result.

Can you post the trace with the axes labelled?

How to make a DEXA comparison mean anything.

Same machine, same clinic, same protocol. Same hydration and fasting state, as far as you can manage. At least three to four months apart, because the measurement error is large relative to short-term change. Three scans rather than two, because the first pair cannot distinguish a trend from noise.

Do less than that and you have two numbers with an offset of unknown size, which people then react to by rebuilding a training programme. The free alternative — a few tracked lifts and a monthly waist measurement — is directionally informative, costs nothing, and is far harder to over-interpret.

integration decisions move the number more than the sample does

batch number, date of analysis, method, individual impurities — that is the minimum set

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

Fixing my own comment above: I said 8 orders and it is 32. The pattern is the same, the count was wrong.

a single DEXA is a number, two is a comparison, three is a trend

Push back: strength dropping in a deficit is not the same as lean mass loss. Related, not identical.

reproducibility beats resolution if you only get one of them

Can you post the trace with the axes labelled?

the appetite signal and the scale move on different clocks

Is that a U-100 syringe? The barrel markings change the answer completely.

Delayed gastric emptying is most pronounced early and attenuates with continued dosing, which is why the reflux usually fades at a stable dose.

This. Intention-to-treat versus completer analysis routinely moves the headline by several points.

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.

What does the method line actually say? Not the technique — the column and the gradient.

Careful with that mean. The distribution around it was wide enough that it describes very few individual participants.

Same experience with the appetite effect being flatter across the week rather than front-loaded.

Pen or vial? The step sizes available differ and it changes this answer.

BCH sent me the column, the gradient and the theoretical mass without being asked. That is a short list and they are on it.